Skip to main navigation Skip to search Skip to main content

Relationship between early-pregnancy glycemia and adverse outcomes: findings from the TOBOGM Study

  • Arianne Sweeting
  • , Joanne Enticott
  • , Jincy Immanuel
  • , William M. Hague
  • , Helena Teede
  • , Christopher J. Nolan
  • , Michael J. Peek
  • , Jeff R. Flack
  • , Mark McLean
  • , Vincent W. Wong
  • , Emily J. Hibbert
  • , Alexandra Kautzky-Willer
  • , Jürgen Harreiter
  • , Helena Backman
  • , Emily Gianatti
  • , Viswanathan Mohan
  • , N. Wah Cheung
  • , David Simmons
  • , TOBOGM Research Group
  • Royal Prince Alfred Hospital
  • Monash University
  • University of Adelaide
  • Australian National University
  • Bankstown-Lidcombe Hospital
  • Blacktown Hospital
  • University of New South Wales
  • The University of Sydney
  • Medical University of Vienna
  • Landesklinikum Scheibbs
  • Örebro University
  • Fiona Stanley Hospital
  • Dr. Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

We evaluated associations between early-pregnancy oral glucose tolerance test (OGTT) glucose and complications in the Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) cohort to inform prognostic OGTT thresholds. RESEARCH DESIGN AND METHODS Individuals with risk factors for hyperglycemia were recruited for an international, multicenter, randomized controlled gestational diabetes mellitus (GDM) (World Health Organization 2013 criteria) treatment trial. A 2-h 75-g OGTT was performed at <20 weeks’ gestation. Individuals with early treated hyperglycemia in pregnancy were excluded fromthe primary analysis. Early OGTT glucose concentrations were analyzed continuously and in glycemic categories (normal, low band, and high band). RESULTS Overall, 3,645 individuals had an OGTT at (mean ± SD) 15.6 ± 2.5 weeks. For each 1-SD increase in fasting, 1-h, and 2-h glucose values, there were continuous positive associations with late GDM: adjusted odds ratio (aOR) 2.04 (95% CI 1.82-2.27), 3.05 (2.72-3.43), and 2.21 (1.99-2.45), respectively. There were continuous positive associations between 1-h and 2-h glucose and the perinatal composite (birth <37 + 0 weeks, birth trauma, birth weight $4,500 g, respiratory distress, phototherapy requirement, stillbirth/neonatal death, and shoulder dystocia), with aOR 1.15 (95% CI 1.04-1.26) and 1.14 (1.04-1.25), respectively, and with large-for-gestational-age offspring, with aOR 1.18 (1.06-1.31) and 1.26 (1.01-1.25), respectively. Significant associations were also observed between 1-h glucose and cesarean section and between fasting and 2-h glucose and neonatal hypoglycemia. In categorical analysis, only the high-band 1-h glucose ($10.6mmol/L [191mg/dL]) predicted the perinatal composite. CONCLUSIONS There is a continuous positive association between early-pregnancy OGTT glucose and complications. In individuals with hyperglycemia risk factors, only the high-glycemic-band 1-h glucose corresponded to increased risk of major perinatal complications.

Original languageEnglish
Pages (from-to)2085-2092
Number of pages8
JournalDiabetes care
Volume47
Issue number12
DOIs
Publication statusPublished - 1 Dec 2024

Notes


UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Relationship between early-pregnancy glycemia and adverse outcomes: findings from the TOBOGM Study'. Together they form a unique fingerprint.

Cite this